Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients
Clinical trial NCT02903004 · COMPLETED
Trial details
- NCT number
- NCT02903004
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-11
- Primary completion
- 2018-12-20
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.